Biomay AG   Report issue

For profit Phase 1 Phase 2
Founded: Vienna Austria (1984)

Organization Overview

First Clinical Trial
2011
NCT01350635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Biomay AG | Viravaxx AG